{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:31Z","timestamp":1786120231657,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4,1]]},"DOI":"10.1097\/qai.0b013e318245d3c1","type":"journal-article","created":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T04:22:09Z","timestamp":1326342129000},"page":"e60-e71","source":"Crossref","is-referenced-by-count":27,"title":["Long-Term Antiretroviral Treatment Outcomes in Seven Countries in the Caribbean"],"prefix":"10.1097","volume":"59","author":[{"given":"Serena P.","family":"Koenig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtenay","family":"Bartholomew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracie E.","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Barrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Cabi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Vasquez-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avion","family":"Quava-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Adomakoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Peter Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Liautaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magaly","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean W.","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-17-20210131","doi-asserted-by":"crossref","first-page":"e4814","DOI":"10.1371\/journal.pone.0004814","article-title":". HIV-1 epidemic in the Caribbean is dominated by subtype B.","volume":"4","author":"Nadai","year":"2009","journal-title":"PLoS One"},{"key":"R5-17-20210131","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(06)68580-2","article-title":". Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.","volume":"367","author":"Ferradini","year":"2006","journal-title":"Lancet"},{"key":"R6-17-20210131","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/431199","article-title":"Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature.","volume":"41","author":"Ivers","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R7-17-20210131","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(08)60693-5","article-title":". Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi.","volume":"371","author":"Jahn","year":"2008","journal-title":"Lancet"},{"key":"R8-17-20210131","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMoa051908","article-title":". Antiretroviral therapy in a thousand patients with AIDS in Haiti.","volume":"353","author":"Severe","year":"2005","journal-title":"N Engl J Med"},{"key":"R9-17-20210131","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":". Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.","volume":"367","author":"Braitstein","year":"2006","journal-title":"Lancet"},{"key":"R10-17-20210131","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.296.7.782","article-title":". Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.","volume":"296","author":"Stringer","year":"2006","journal-title":"JAMA"},{"key":"R11-17-20210131","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/QAD.0b013e3282f768f8","article-title":". Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote dIvoire: 2-year outcomes and determinants.","volume":"22","author":"Toure","year":"2008","journal-title":"AIDS"},{"key":"R12-17-20210131","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/QAD.0b013e328012c54f","article-title":". Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.","volume":"21","author":"Madec","year":"2007","journal-title":"AIDS"},{"key":"R13-17-20210131","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1097\/QAD.0b013e3283129db0","article-title":". Five-year outcomes of initial patients treated in Botswanas National Antiretroviral Treatment Program.","volume":"22","author":"Bussmann","year":"2008","journal-title":"AIDS"},{"key":"R14-17-20210131","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/01.aids.0000226959.87471.01","article-title":". Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.","volume":"20","author":"Etard","year":"2006","journal-title":"AIDS"},{"key":"R15-17-20210131","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00126334-200501010-00003","article-title":". Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults.","volume":"38","author":"Laurent","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-17-20210131","doi-asserted-by":"crossref","first-page":"e18453","DOI":"10.1371\/journal.pone.0018453","article-title":". Four-year treatment outcomes of adult patients enrolled in mozambiques rapidly expanding antiretroviral therapy program.","volume":"6","author":"Auld","year":"2011","journal-title":"PLoS One"},{"key":"R17-17-20210131","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1758-2652-12-38","article-title":". Long term outcomes of antiretroviral therapy in a large HIVAIDS care clinic in urban South Africa: a prospective cohort study.","volume":"12","author":"Sanne","year":"2009","journal-title":"J Int AIDS Soc"},{"key":"R18-17-20210131","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJMc0809485","article-title":". 5-year survival of patients with AIDS receiving antiretroviral therapy in Haiti.","volume":"361","author":"Leger","year":"2009","journal-title":"N Engl J Med"},{"key":"R19-17-20210131","first-page":"315","article-title":". Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa.","volume":"96","author":"Bekker","year":"2006","journal-title":"S Afr Med J"},{"key":"R20-17-20210131","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/QAD.0b013e328333bfb7","article-title":". Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.","volume":"24","author":"Boulle","year":"2010","journal-title":"AIDS"},{"key":"R21-17-20210131","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/QAI.0b013e3181ff0bdc","article-title":". Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa.","volume":"56","author":"Nglazi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R22-17-20210131","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1365-3156.2009.02334.x","article-title":". Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia.","volume":"14","author":"Thai","year":"2009","journal-title":"Trop Med Int Health"},{"key":"R24-17-20210131","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1097\/QAD.0b013e32828cc8b7","article-title":". Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia.","volume":"21","author":"Ferradini","year":"2007","journal-title":"AIDS"},{"key":"R25-17-20210131","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/135965350901400113","article-title":". Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa.","volume":"14","author":"Van der Borght","year":"2009","journal-title":"Antivir Ther"},{"key":"R26-17-20210131","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1097\/QAD.0b013e3283121ca9","article-title":". Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.","volume":"22","author":"Nash","year":"2008","journal-title":"AIDS"},{"key":"R27-17-20210131","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/QAI.0b013e31802f8512","article-title":". Brief report: effectiveness of combination antiretroviral therapy on survival and opportunistic infections in a developing world setting: an observational cohort study.","volume":"44","author":"Corey","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R28-17-20210131","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00002030-200404090-00006","article-title":". Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa.","volume":"18","author":"Coetzee","year":"2004","journal-title":"AIDS"},{"key":"R29-17-20210131","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/00002030-200207050-00008","article-title":". The Senegalese governments highly active antiretroviral therapy initiative: an 18-month follow-up study.","volume":"16","author":"Laurent","year":"2002","journal-title":"AIDS"},{"key":"R30-17-20210131","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/QAI.0b013e3181eb4fb9","article-title":". Long-term outcomes of a national expanded access program to antiretroviral therapy: the Chilean AIDS cohort.","volume":"55","author":"Wolff","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R31-17-20210131","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1371\/journal.pmed.0040298","article-title":"Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.","volume":"4","author":"Rosen","year":"2007","journal-title":"PLoS Med"},{"issue":"Suppl 1","key":"R32-17-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3156.2010.02508.x","article-title":"Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.","volume":"15","author":"Fox","year":"2010","journal-title":"Trop Med Int Health"},{"key":"R34-17-20210131","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1468-1293.2006.00347.x","article-title":". Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.","volume":"7","author":"Kilaru","year":"2006","journal-title":"HIV Med"},{"key":"R35-17-20210131","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/QAI.0b013e3181a44f0a","article-title":". Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean.","volume":"51","author":"Tuboi","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R42-17-20210131","first-page":"853","article-title":". Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy.","volume":"97","author":"Maskew","year":"2007","journal-title":"S Afr Med J"},{"key":"R43-17-20210131","doi-asserted-by":"crossref","first-page":"e1725","DOI":"10.1371\/journal.pone.0001725","article-title":". Overestimates of survival after HAART: implications for global scale-up efforts.","volume":"3","author":"Bisson","year":"2008","journal-title":"PLoS One"},{"key":"R44-17-20210131","doi-asserted-by":"crossref","first-page":"e5790","DOI":"10.1371\/journal.pone.0005790","article-title":"Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.","volume":"4","author":"Brinkhof","year":"2009","journal-title":"PLoS One"},{"key":"R45-17-20210131","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(10)60666-6","article-title":". Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.","volume":"376","author":"May","year":"2010","journal-title":"Lancet"},{"key":"R46-17-20210131","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1086\/593312","article-title":". Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral-treated patients in sub-Saharan African sites with comprehensive monitoring availability.","volume":"48","author":"Palombi","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R47-17-20210131","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1097\/QAD.0b013e3283305a00","article-title":". Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.","volume":"23","author":"Lanoy","year":"2009","journal-title":"AIDS"},{"key":"R49-17-20210131","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1365-3156.2008.02078.x","article-title":". Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America.","volume":"13","author":"Keiser","year":"2008","journal-title":"Trop Med Int Health"},{"key":"R53-17-20210131","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1360-0443.2009.02827.x","article-title":". Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study.","volume":"105","author":"Larsen","year":"2010","journal-title":"Addiction"},{"key":"R54-17-20210131","first-page":"174","article-title":". Trends in the HIV and AIDS epidemic in a Puerto Rican cohort of patients: 1992-2005.","volume":"98","author":"Baez-Feliciano","year":"2006","journal-title":"Bol Asoc Med P R"},{"key":"R55-17-20210131","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/QAI.0b013e3181b31b8a","article-title":". Differential survival benefit of universal HAART access in Brazil: a nation-wide comparison of injecting drug users versus men who have sex with men.","volume":"52","author":"Malta","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R56-17-20210131","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2471\/BLT.07.044248","article-title":". Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.","volume":"86","author":"Brinkhof","year":"2008","journal-title":"Bull World Health Organ"},{"key":"R58-17-20210131","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/QAI.0b013e31815b833a","article-title":". Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa.","volume":"47","author":"Dalal","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R60-17-20210131","first-page":"405","article-title":". Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa.","volume":"15","author":"Fox","year":"2010","journal-title":"Trop Med Int Health"},{"key":"R61-17-20210131","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2471\/BLT.06.037739","article-title":". True outcomes for patients on antiretroviral therapy who are lost to follow-up in Malawi.","volume":"85","author":"Yu","year":"2007","journal-title":"Bull World Health Organ"},{"key":"R62-17-20210131","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/09540120701594776","article-title":". Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia.","volume":"20","author":"Krebs","year":"2008","journal-title":"AIDS Care"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201204010-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:29:52Z","timestamp":1786048192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201204010-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,1]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318245d3c1","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4,1]]}}}